Flück C E, Kuhlmann B V, Mullis P E
Abteilung Pädiatrische Diabetologie und Endokrinologie, Universitäts-Kinderklinik, Inselspital, Bern.
Schweiz Med Wochenschr. 1999 Nov 6;129(44):1650-5.
AIMS/HYPOTHESIS: In diabetes mellitus type I, good glycaemic control is crucial in preventing long-term diabetic complications. The aim of this study was to determine the current level of metabolic control in children and adolescents in our diabetes outpatient clinic at the University Children's Hospital, Berne. Furthermore, the impact of different factors such as age, pubertal stage, sex, duration of diabetes and insulin regimen on glycaemic control was studied.
In a cross-sectional, prospective study 168 children and adolescents with type I diabetes mellitus (f:m = 87:81; prepubertal 48 [mean age 4.4 years, mean duration of diabetes 2.8 years]; pubertal 120 [mean age 9.4 years; mean duration of diabetes 5.2 years]) were studied for three months. Clinical data and HbA1c levels (latex immunoagglutination test) were recorded, statistically analysed and compared with the international literature.
In our type I diabetic children and adolescents the overall HbA1c was 8.07 +/- 1.15% (mean +/- SD; test-specific norm for healthy subjects: 4.1-6.1%). Glycaemic control was significantly worse in the pubertal group compared to the prepubertal (HbA1c 8.22 +/- 1.25% vs. 7.81 +/- 0.87%; p < 0.01). In addition, we found better metabolic control in patients with duration of diabetes below 2 years in children and adolescents (HbA1c prepubertal < 2 years: 7.45 +/- 0.67% vs. > 2 years: 8.05 +/- 0.93%, p < 0.05; pubertal < 2 years: 7.62 +/- 0.75% vs. > 2 years: 8.31 +/- 1.29%, p < 0.005). Importantly, sex and insulin regimen did not significantly influence glycaemic control.
CONCLUSION/INTERPRETATION: The current level of metabolic control in our children and adolescents with diabetes mellitus type I is comparable to the glycaemic control of the intensively treated adolescent group of the DCCT-study, in whom decreased risk of long-term diabetic complications was found. In contrast, our patients were intensively treated in terms of frequent contacts with the diabetes team, but were not necessarily on an intensified insulin regimen. The impact of biopsychosocial support from multidisciplinary diabetes team on good metabolic control in children and adolescents with type I diabetes mellitus and their families seems to be very important.
目的/假设:在1型糖尿病中,良好的血糖控制对于预防长期糖尿病并发症至关重要。本研究的目的是确定伯尔尼大学儿童医院糖尿病门诊中儿童和青少年目前的代谢控制水平。此外,还研究了年龄、青春期阶段、性别、糖尿病病程和胰岛素治疗方案等不同因素对血糖控制的影响。
在一项横断面前瞻性研究中,对168例1型糖尿病儿童和青少年(女:男 = 87:81;青春期前48例[平均年龄4.4岁,平均糖尿病病程2.8年];青春期120例[平均年龄9.4岁;平均糖尿病病程5.2年])进行了为期三个月的研究。记录临床数据和糖化血红蛋白(HbA1c)水平(乳胶免疫凝集试验),进行统计分析并与国际文献进行比较。
在我们的1型糖尿病儿童和青少年中,总体HbA1c为8.07±1.15%(平均值±标准差;健康受试者的特定检测标准:4.1 - 6.1%)。与青春期前组相比,青春期组的血糖控制明显更差(HbA1c 8.22±1.25%对7.81±0.87%;p < 0.01)。此外,我们发现儿童和青少年中糖尿病病程低于2年的患者代谢控制更好(青春期前<2年:HbA1c 7.45±0.67%对>2年:8.05±0.93%,p < 0.05;青春期<2年:7.62±0.75%对>2年:8.31±1.29%,p < 0.005)。重要的是,性别和胰岛素治疗方案对血糖控制没有显著影响。
结论/解读:我们的1型糖尿病儿童和青少年目前的代谢控制水平与糖尿病控制与并发症试验(DCCT)研究中强化治疗的青少年组的血糖控制相当,在该组中发现长期糖尿病并发症的风险降低。相比之下,我们的患者在与糖尿病团队频繁接触方面接受了强化治疗,但不一定采用强化胰岛素治疗方案。多学科糖尿病团队提供的生物心理社会支持对1型糖尿病儿童和青少年及其家庭良好的代谢控制的影响似乎非常重要。